Company Filing History:
Years Active: 1996-2004
Title: Richard Walter Schevitz: Innovator in Pharmaceutical Chemistry
Introduction
Richard Walter Schevitz is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work primarily focuses on developing novel compounds that have therapeutic applications.
Latest Patents
Among his latest patents, Richard has developed a class of novel tricyclics aimed at inhibiting sPLA mediated release of fatty acids. These compounds are particularly relevant for treating conditions such as septic shock. Additionally, he has disclosed a class of novel 1H-indole-3-acetamides, which also serve as sPLA2 inhibitors for similar therapeutic purposes.
Career Highlights
Richard Walter Schevitz is currently associated with Eli Lilly and Company, a leading global pharmaceutical company. His innovative work has contributed to advancements in drug development and therapeutic solutions.
Collaborations
Throughout his career, Richard has collaborated with esteemed colleagues, including Nicholas J Bach and Susan Elizabeth Draheim. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Richard Walter Schevitz exemplifies the spirit of innovation in pharmaceutical chemistry through his patents and collaborations. His contributions continue to impact the field positively.